InvestorsHub Logo
Followers 60
Posts 7125
Boards Moderated 0
Alias Born 03/20/2017

Re: a1tellem post# 64682

Sunday, 05/28/2017 10:53:26 AM

Sunday, May 28, 2017 10:53:26 AM

Post# of 106837
I'll give you my opinion but before I do I don't want to get jumped on for it lol. I'll also state I'm no wall street professional but I am educated in business. For me stem cell has a ton of upside, but after researching USRM, the whole operation seems sketchy to me. The company doesn't seem to have a close grip on it's treatment centers, leading to botched procedures and stalled trials. Just because they decide to apply for RMAT doesn't mean they have a way ahead. RMAT doesn't really mean anything. They're losing a ton of money year after year and is basically on life support. I don't see RMAT doing anything for this company because they are going out of business well before they can develop Myocell. Any potential buy out will be for pennies on the dollar just to bail out the entities involved with the company's debt. I sincerely hope the PPS spikes for yall if RMAT is approved, but this was not a play I wanted to risk playing.